OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Adenosine A2AR/A1R Antagonists Enabling Additional H3R Antagonism for the Treatment of Parkinson’s Disease
Stefanie Hagenow, Anna Affini, Elsa Y. Pioli, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 8246-8262
Closed Access | Times Cited: 10
Stefanie Hagenow, Anna Affini, Elsa Y. Pioli, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 8246-8262
Closed Access | Times Cited: 10
Showing 10 citing articles:
Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now?
Lisa Sequeira, Sofia Benfeito, Carlos Fernandes, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 708-708
Open Access | Times Cited: 6
Lisa Sequeira, Sofia Benfeito, Carlos Fernandes, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 708-708
Open Access | Times Cited: 6
A2A Adenosine Receptor Antagonists in Neurodegenerative Diseases
Stefania Merighi, Pier Andrea Borea, Katia Varani, et al.
Current Medicinal Chemistry (2021) Vol. 29, Iss. 24, pp. 4138-4151
Open Access | Times Cited: 28
Stefania Merighi, Pier Andrea Borea, Katia Varani, et al.
Current Medicinal Chemistry (2021) Vol. 29, Iss. 24, pp. 4138-4151
Open Access | Times Cited: 28
Integrating Atom‐Based 3D‐QSAR, Molecular Docking, and Molecular Dynamics: A Multistep Approach for the Discovery of Potent Adenosine A2A Receptor Antagonists
Sachithra Thazhathuveedu Sudevan, Namitha Chandran, V.R. Vishnu, et al.
ChemistrySelect (2025) Vol. 10, Iss. 12
Closed Access
Sachithra Thazhathuveedu Sudevan, Namitha Chandran, V.R. Vishnu, et al.
ChemistrySelect (2025) Vol. 10, Iss. 12
Closed Access
Caffeine Inhibits Activation of the NLRP3 Inflammasome via Autophagy to Attenuate Microglia-Mediated Neuroinflammation in Experimental Autoimmune Encephalomyelitis
Huiqi Wang, Kai-Yi Song, Jinzhou Feng, et al.
Journal of Molecular Neuroscience (2021) Vol. 72, Iss. 1, pp. 97-112
Closed Access | Times Cited: 26
Huiqi Wang, Kai-Yi Song, Jinzhou Feng, et al.
Journal of Molecular Neuroscience (2021) Vol. 72, Iss. 1, pp. 97-112
Closed Access | Times Cited: 26
Discovery of Pyridone-Substituted Triazolopyrimidine Dual A2A/A1 AR Antagonists for the Treatment of Ischemic Stroke
Mei‐Lin Tang, Zihao Wen, Jinghuan Wang, et al.
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 3, pp. 436-442
Open Access | Times Cited: 5
Mei‐Lin Tang, Zihao Wen, Jinghuan Wang, et al.
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 3, pp. 436-442
Open Access | Times Cited: 5
Experimental Studies Indicate That ST-2223, the Antagonist of Histamine H3 and Dopamine D2/D3 Receptors, Restores Social Deficits and Neurotransmission Dysregulation in Mouse Model of Autism
Nermin Eissa, Karthikkumar Venkatachalam, Petrilla Jayaprakash, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 929-929
Open Access | Times Cited: 5
Nermin Eissa, Karthikkumar Venkatachalam, Petrilla Jayaprakash, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 929-929
Open Access | Times Cited: 5
Bis(benzimidazol‐2‐yl)amine‐based DPP‐4 Inhibitors Potentially Suitable for Combating Diabetes and Associated Nervous System Alterations
Katarina Tomović Pavlović, Budimir S. Ilić, Luisa Leitzbach, et al.
Chemistry & Biodiversity (2024)
Closed Access
Katarina Tomović Pavlović, Budimir S. Ilić, Luisa Leitzbach, et al.
Chemistry & Biodiversity (2024)
Closed Access
Histamine H 3 receptor antagonists/inverse agonists: a patent review (October 2017- December 2023) documenting progress
Dorota Łażewska, Katarzyna Kieć‐Kononowicz
Expert Opinion on Therapeutic Patents (2024), pp. 1-25
Open Access
Dorota Łażewska, Katarzyna Kieć‐Kononowicz
Expert Opinion on Therapeutic Patents (2024), pp. 1-25
Open Access
Bifunctional Tools to Study Adenosine Receptors
China M. Payne, Jon Kyle Awalt, Lauren T. May, et al.
Topics in medicinal chemistry (2022), pp. 179-221
Closed Access | Times Cited: 2
China M. Payne, Jon Kyle Awalt, Lauren T. May, et al.
Topics in medicinal chemistry (2022), pp. 179-221
Closed Access | Times Cited: 2
Once Upon a Time Adenosine and Its Receptors: Historical Survey and Perspectives as Potential Targets for Therapy in Human Diseases
Daniela Catarzi, Flavia Varano, Sara Calenda, et al.
Topics in medicinal chemistry (2023), pp. 1-46
Closed Access
Daniela Catarzi, Flavia Varano, Sara Calenda, et al.
Topics in medicinal chemistry (2023), pp. 1-46
Closed Access
